0
Article |

Kawasaki's Disease FREE

JERRY C. JACOBS, MD
Am J Dis Child. 1981;135(1):82. doi:10.1001/archpedi.1981.02130250068024.
Text Size: A A A
Published online

Sir.—Yanagihara and Todd in their invited review of Kawasaki's disease (Journal 1980;134:606-614) failed to refer to prior reports by myself and my colleagues on the occurrence of Kawasaki's disease in epidemic form in the United States, the efficacy of both aspirin and corticosteroids in controlling symptoms when administered in adequate doses, and the malabsorption of aspirin in some children with Kawasaki's disease.1,2 Subsequent experience with more than 60 cases of Kawasaki's disease in our registry, and many more reported to us via telephone consultation by many physicians from many areas of the United States, confirms our original observations. While Yanagihara and Todd do not refer directly to our data, our 23 cases reported between April 1977 and February 1978, plus 23 more cases studied in the metropolitan New York City area during that period as part of a joint epidemiologic study with the Center for Disease Control

REFERENCES

Jacobs JC:  Successful treatment of Kawasaki disease with high-dose aspirin . Pediatr Res 1978;;12:494.
Jacobs JC:  Salicylate treatment of epidemic Kawasaki disease in New York City . Ther Drug Monitor 1979;;1:123-130.
Morens DM, Anderson LJ, Hurwitz ES:  National surveillance of Kawasaki disease . Pediatrics 1980;;65:21-25.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Jacobs JC:  Successful treatment of Kawasaki disease with high-dose aspirin . Pediatr Res 1978;;12:494.
Jacobs JC:  Salicylate treatment of epidemic Kawasaki disease in New York City . Ther Drug Monitor 1979;;1:123-130.
Morens DM, Anderson LJ, Hurwitz ES:  National surveillance of Kawasaki disease . Pediatrics 1980;;65:21-25.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.